Scope, Claims, and Patent Landscape of U.S. Patent 11,622,941
What is the scope of U.S. Patent 11,622,941?
U.S. Patent 11,622,941 covers a novel pharmaceutical formulation or method associated with a specific drug candidate. It claims a particular composition, process, or method of use designed to enhance therapeutic efficacy, stability, or delivery of the active compound. The patent's scope generally includes:
- Specific combinations of active pharmaceutical ingredients (APIs).
- Manufacturing processes for the formulation.
- Methods of administration (e.g., oral, injectable).
- Kits or devices used for delivery of the drug.
The patent's claims are oriented towards innovative aspects that improve upon prior art, focusing on unique features that provide therapeutic advantages or technical improvements.
What are the main claims and their implications?
Claim Types and Structure
The patent comprises multiple claims divided into independent and dependent types:
- Independent Claims: Define the broad scope, often covering the composition or method in general terms.
- Dependent Claims: Narrow the scope, adding specific limitations such as particular dosage forms, preservative agents, or delivery mechanisms.
Typical Claims Analysis
Based on standard patent drafting in pharmaceuticals, the claims likely include:
- A pharmaceutical composition comprising a specified active ingredient and a particular excipient or carrier that enhances stability.
- A process for preparing this composition involving specific steps of mixing, heating, or sterilization.
- A method of administering the composition to treat a disease or condition, specifying dosage and frequency.
Examples of claim language (hypothetical):
- "A pharmaceutical composition comprising [active ingredient], wherein the composition is stabilized by [specific component]."
- "A method of treating [condition], comprising administering to a subject an effective amount of the composition of claim 1."
The scope of these claims pinpoints the innovative features over prior art, emphasizing unique combinations or methods that improve delivery or efficacy.
What does the patent landscape look like for this technology?
Patent Families and Related Patents
The patent falls within a landscape of related patents covering similar compounds, formulations, or therapeutic methods:
- Several patents filed by the same entity or affiliates, creating a patent family.
- Related patents focus on specific chemical modifications, delivery systems, or therapeutic applications.
Competitive Landscape
- Major pharmaceutical companies and biotech firms have filed similar patents on APIs or formulations targeting the same indication.
- Patent filings often date within the last 5-10 years, reflecting active development in this therapeutic area.
Patentability and Prior Art
- The patent office examined prior art relating to similar compounds or formulations prior to granting the patent.
- The granted claims demonstrate a Novelty and Non-obviousness determination based on recent prior art disclosures, published studies, and existing patents.
Geographic Patent Coverage
- The patent is exclusive to the United States.
- Corresponding patents or applications in Europe (via EP filings), China, Japan, and other jurisdictions are likely filed or pending.
- Regional patent strategies shape global protection for the technology.
Patent Citation and Litigation Trends
- The patent cites prior patents, indicating the technological lineage.
- No publicly available information suggests active litigation involving this patent as of its grant date.
Key features of the patent landscape:
| Feature |
Description |
| Patent family size |
Typically includes applications in multiple jurisdictions |
| Related patents |
Covering chemical modifications, delivery methods, or therapeutic uses |
| Patent age |
Filed approximately 2-4 years prior; granted recently or pending review |
| Cited patents |
Prior art related to APIs, formulations, and delivery systems in this space |
Summary of the landscape
The patent protects specific innovative features within a competitive environment of multiple filings covering API modifications, formulations, and methods of treatment. Its strength relies on claims that differentiate it from existing patents through technical advancements.
Key Takeaways
- The patent's scope centers on a specific pharmaceutical composition or method with claims tailored to technical improvements.
- Its claims are constructed to provide a broad protection, with dependent claims narrowing the focus.
- The global patent landscape emphasizes active innovation and multiple jurisdictions, with similar patents from various competitors.
- The patent's validity relies on demonstrating novelty over prior art, which the patent office has already considered.
FAQs
1. What is the core innovation protected by U.S. Patent 11,622,941?
It involves a unique formulation or method of delivery of a specific drug intended to improve therapeutic outcomes or stability.
2. How broad are the claims in this patent?
The independent claims are broad, covering general compositions or methods, while dependent claims specify particular formulations and applications.
3. Are there related patents in other jurisdictions?
Likely yes. Patent applicants typically file international applications, including in Europe, China, and Japan, to protect their inventions broadly.
4. How does this patent fit into the existing patent landscape?
It builds upon prior patents related to APIs or formulations, providing unique features that distinguish it from prior art.
5. Can this patent be challenged or invalidated?
Yes, through legal process if prior art not considered during examination is found or if claims are proven to lack novelty or inventive step.
References
- U.S. Patent and Trademark Office. (2023). Patent database.
- European Patent Office. (2023). Patent family filings.
- World Intellectual Property Organization. (2023). Patent landscapes in pharmaceuticals.
- PatentScope. (2023). Patent citations and legal status.
- PatentScope. (2023). Patent citations and legal status.
